Media headlines about Alphatec Holdings (NASDAQ:ATEC) have been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alphatec Holdings earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave press coverage about the medical technology company an impact score of 46.0275619425671 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- NuVasive files lawsuit against former vice chairman (dotmed.com)
- Nuvasive wins expanded clearance for Precice (medicaldevicedaily.com)
- NuVasive Says Exec Breached Contract In Move To Alphatec (law360.com)
- Spinal Fusion Systems – Medical Devices Pipeline Assessment, 2017 (rnrmarketresearch.com)
- Alphatec Holdings Denounces ???Baseless??? NuVasive Complaint (biospace.com)
Several research firms have issued reports on ATEC. HC Wainwright began coverage on Alphatec Holdings in a report on Monday, August 14th. They set a “buy” rating and a $4.00 price objective on the stock. ValuEngine downgraded Alphatec Holdings from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Finally, Lake Street Capital initiated coverage on Alphatec Holdings in a research note on Monday. They issued a “buy” rating and a $7.00 price target for the company.
Alphatec Holdings (NASDAQ:ATEC) opened at 3.71 on Tuesday. The company has a 50 day moving average price of $2.56 and a 200-day moving average price of $2.08. Alphatec Holdings has a 52 week low of $1.58 and a 52 week high of $6.98. The firm’s market capitalization is $40.98 million.
Alphatec Holdings (NASDAQ:ATEC) last issued its quarterly earnings results on Thursday, August 10th. The medical technology company reported ($0.32) EPS for the quarter. The company had revenue of $24.38 million during the quarter. Equities analysts predict that Alphatec Holdings will post ($1.20) earnings per share for the current year.
Alphatec Holdings Company Profile
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with our FREE daily email newsletter.